Oncology and Technology

The OCM (Oncology Care Model), launched in 2016, is a payment model designed to help oncology centers transition from the traditional Medicare Fee-for-Service (FFS) payment structure and focus on high-value care.The EOM (Enhancing Oncology Model) is the next phase model and will replace OCM starting July 1, 2023. EOM will support clinicians caring for patients with seven common cancer types, focusing on health equity and accountable, affordable care.But what are the revenue-enhancing opportunities in EOM, is it worth the transition from OCM, and what does it actually provide?On today's episode of Technology and Oncology Podcast, host Michelle Dawn Mooney speaks with John Elliot, the Vice President of Sales at Carevīve to discuss how oncology centers and clinics can transition from OCM to EOM and how they can get assistance for the process.Michelle Dawn Mooney and John Elliot discussed:1. What clients should expect after approval and assistance available to meet the July 1 deadline for launching2. Benefits of EOM to oncology patients3. Where people can find more information and assistance on the topic“Looking at oncology, efficiency is key, however, there are limited constrained resources. 24/7 access to electronic records, having a line of communication, capturing symptoms at the right time, access to care with the focus of addressing challenges in the oncology and health care sector which can improve patient outcome and reduce cost – this is what the EOM aims to achieve. The EOM model bridges the gap of communication and ensures members of the care team are aware of what is happening in real-time, which promotes standardization of care,” explained John Elliot.John Elliot is the Vice President of Sales at Carevīve. He received his Bachelor of Arts degree in Advertising from Southern Methodist University and his Master of Business Administration from Washington University in St. Louis-Olin Business School. He has over ten years of experience working with oncology centers.

For anyone working in the oncology field, a highly anticipated change set to take place will be one of the biggest transitions in recent years. Last year, it was announced that the Oncology Care Model (OCM) will be phased out and succeeded with the Enhanced Oncology Model (EOM). This new model will go into effect in July 2023 and help improve care for cancer patients. What are the people who work in the oncology field most looking forward to with the forthcoming new model implementation? And what are their expectations for cancer care?In the latest episode of “Oncology and Technology,” host Tyler Kern sat down to interview with several members of the Carevive team, John Elliot, VP of Sales; Reesa Sherin, Clinical Strategist; and April Boyd, Clinical Product Manager, mostly about the state of the oncology, and what current trends will remain or seeing advancements next year.Kern, Elliot, Sherin, and Boyd also talked about … 1. Educational events held in preparation for the shift to EOM2. What clinicians will value in terms of the new models and how they expect to implement3. How the shift will change oncology and cancer patient care“The big shift, I think, just in healthcare broadly and then specifically to oncology, has been continued evaluation and how health systems and cancer centers are evaluating a shift to value-based care from the traditional … service,” said Elliot.John Elliot is the Vice President of Sales at Carevive. He has been with the company for almost four years and held a previous senior position at Cerner Corporation. Elliot is a graduate of Southern Methodist University and Washington University in St. Louis - Olin Business School. Reesa Sherin is Carevive's Clinical Strategist and is a MSN and RN. She has been with the company for six years and is a graduate of Temple University and Thomas Jefferson University. April Boyd is the Clinical Product Manager at Carevive and has been in that role for three years now. Prior to that she worked at the MD Anderson Cancer Center.

Information plays a crucial role for many oncology professionals out there – treatment care planning, clinical trial screening, and more. However, implementing nursing informatics comes with a fair set of changes, especially when it comes to driving adoption. Combined data is a powerful tool for medical professionals to act swiftly to different measures, but in the grand scheme of things, is cost-effective and enhances patient outcomes. On this episode of Oncology and Technology, host Tyler Kern talks to VP of Client Success for CAREVIVE, Dr. Nadia Still. Dr. Still offers her insights into what client success looks like at Carevive, and the basis for Carevive as a platform that moves theoretical learnings out of research and into everyday medical practices. This episode features: • Carevive as a platform that drives medical implementation science from theoretical learnings to best practices. • Dr. Still explains her role as the VP of Client Success for Carevive and what made her team the right fit for the company. • Building relationships with clients, understanding project objectives, and defining KPI's“The most important thing is to not only understand the goals, but how we'll measure our success and our progress towards those goals. That really is truly a key indicator of if we're on target or if we need to make adjustments,” Dr. Still said. Dr. Still is a Doctor of Nursing Practices by trade and manages accounts for senior-level clients and partners within the medical industry. She earned her BSN from Widener University and MSN from Rutgers University. Dr. Still earned her DNP from Thomas Jefferson University.

Quality cancer care is important to the well-being of cancer patients, and the government is working to increase the efficiency of care. In a recent Carevive podcast episode, host Michelle Dawn Mooney chatted with Carevive's Founder and Vice Chairman, Madelyn Herzfeld, about the Enhancing Oncology Model, or EOM. Through the Centers for Medicare and Medicaid Service (CMS) EOM, which is a replacement program for the phased-out OCM, or the Oncology Care Model, health providers have completed major improvements in cancer care in a cost-efficient way. Herzfeld, who is an oncology nurse, co-founded Carevive to revamp cancer care, and help cancer care providers meet their patient care goals. “We wanted to support clinicians and patients with tools that all aimed to improve quality — so improve the patient experience and get better quality and better clinical and financial outcomes,” said Herzfeld.With the end of OCM for EOM, Mooney and Herzfeld discussed the transition, and where organizations and providers are with the program's five-year timeline that will begin effective July 1, 2023. Herzfeld said CMS defined “specific care transformation activities result in better clinical outcomes for patients.”She added that the agency has generously funded a lot of practices that have participated in the program and made complete transformations to meet their guidelines. That often included patient care plans, survivorship care plans, and general quality care. Herzfeld also said the adjustments many practices incorporated have been a major encouragement in maintaining those changes and rejoining CMS's efforts. “So, for all of these practices that went through the test of time … they came back to CMS and were excited about all the changes that they had made based on this program and looking for what's next with everything that we've done. That's why CMS came out with this enhancing oncology model,” said Herzfeld.Carevive is a major supporter of practices in deciding on EOM, and the entirety of the process. The new model introduces electronic patient-reported outcomes and patient visit monitoring, as well as health-related social needs, stated Herzfeld. However, one challenge of the program is the performance-based payment model, which means good performance is awarded and performance that doesn't meet the mark translates into paying fees back.This could cost practices in the long run. Herzfeld says Carevive is attentive to that because money can create more problems for a practice trying to meet these targets. “I want to be sensitive of course to the oncology care team, administrators — all the cancer programs out there. They want to do the best job possible. Like all of us everything comes down to dollars and cents,” said Herzfeld.Of course, every practice might not feel that EOM is doable for them, and Herzfeld said that can come down to whether a practice decides to go with EOM or not. However, there are still other options. Herzfeld highly recommended that practices do prior data analysis research to help in their decision-making. EOM is likely not the ideal program for every practice, but in performing preliminary tasks, it can be a huge factor in the best outcome.“It just means there are other avenues to put these quality metrics into place, so I think just making educated decisions and having data to do that is really, really critical,” stated Herzfeld.

Quality cancer care is important to the well-being of cancer patients, and the government is working to increase the efficiency of care. In a recent Carevive podcast episode, host Michelle Dawn Mooney chatted with Carevive's Founder and Vice Chairman, Madelyn Herzfeld, about the Enhancing Oncology Model, or EOM. Through the Centers for Medicare and Medicaid Service (CMS) EOM, which is a replacement program for the phased-out OCM, or the Oncology Care Model, health providers have completed major improvements in cancer care in a cost-efficient way. Herzfeld, who is an oncology nurse, co-founded Carevive to revamp cancer care, and help cancer care providers meet their patient care goals. “We wanted to support clinicians and patients with tools that all aimed to improve quality — so improve the patient experience and get better quality and better clinical and financial outcomes,” said Herzfeld.With the end of OCM for EOM, Mooney and Herzfeld discussed the transition, and where organizations and providers are with the program's five-year timeline that will begin effective July 1, 2023. Herzfeld said CMS defined “specific care transformation activities result in better clinical outcomes for patients.”She added that the agency has generously funded a lot of practices that have participated in the program and made complete transformations to meet their guidelines. That often included patient care plans, survivorship care plans, and general quality care. Herzfeld also said the adjustments many practices incorporated have been a major encouragement in maintaining those changes and rejoining CMS's efforts. “So, for all of these practices that went through the test of time … they came back to CMS and were excited about all the changes that they had made based on this program and looking for what's next with everything that we've done. That's why CMS came out with this enhancing oncology model,” said Herzfeld.Carevive is a major supporter of practices in deciding on EOM, and the entirety of the process. The new model introduces electronic patient-reported outcomes and patient visit monitoring, as well as health-related social needs, stated Herzfeld. However, one challenge of the program is the performance-based payment model, which means good performance is awarded and performance that doesn't meet the mark translates into paying fees back.This could cost practices in the long run. Herzfeld says Carevive is attentive to that because money can create more problems for a practice trying to meet these targets. “I want to be sensitive of course to the oncology care team, administrators — all the cancer programs out there. They want to do the best job possible. Like all of us everything comes down to dollars and cents,” said Herzfeld.Of course, every practice might not feel that EOM is doable for them, and Herzfeld said that can come down to whether a practice decides to go with EOM or not. However, there are still other options. Herzfeld highly recommended that practices do prior data analysis research to help in their decision-making. EOM is likely not the ideal program for every practice, but in performing preliminary tasks, it can be a huge factor in the best outcome.“It just means there are other avenues to put these quality metrics into place, so I think just making educated decisions and having data to do that is really, really critical,” stated Herzfeld.

Carevive exists to improve the lives of cancer patients. But doing that, can't be accomplished without integrating real-time solutions into cancer centers around the nation. In Part Four of “Applying Oncology Expertise at Scale” host Tyler Kern chats with MSN & RN Reesa Sherin, a Clinical Strategist for Carevive Systems, about the importance of the oncology technology solution.As the daughter of a cancer survivor, Sherin has a had a long and profound journey. After starting her nursing background in pediatric cancer before switching to adult oncology, Sherin knew she wanted to work in an environment that could help with symptom management, triage, and resource finding. Sherin said her role, which she has held for the past few years, “help[s] support our new prospective clients with implementing and understanding how it would benefit them in their cancer centers.”Sherin's passion for oncology is evident in the nature of her career and she works to remind everyone that some patients can “get lost in the shuffle.” Sherin said, “These patients need the chronic care that they may not get if they're not ‘elderly'.”Many patients need support throughout their cancer journey and often, team members are stretched thin and act in a “reactive state” to address patient needs. Sherin is working to change this. She said, “So, I understand both the patient care aspects along with the balance that needs to be done with the bottom line of the center resources…”Communication and education play a vital role in addressing the knowledge gap and transforming care. Carevive's patient-reported outcomes act as a window into patient thoughts and ideas. Sherin explained, “[We]...let people know that this is something that's out there, that we can support you and your patients and understanding what's going on in between scheduled visits so that you can proactively engage with patients as opposed to that kind of reactive state…”

Carevive exists to improve the lives of cancer patients. But doing that, can't be accomplished without integrating real-time solutions into cancer centers around the nation. In Part Four of “Applying Oncology Expertise at Scale” host Tyler Kern chats with MSN & RN Reesa Sherin, a Clinical Strategist for Carevive Systems, about the importance of the oncology technology solution.As the daughter of a cancer survivor, Sherin has a had a long and profound journey. After starting her nursing background in pediatric cancer before switching to adult oncology, Sherin knew she wanted to work in an environment that could help with symptom management, triage, and resource finding. Sherin said her role, which she has held for the past few years, “help[s] support our new prospective clients with implementing and understanding how it would benefit them in their cancer centers.”Sherin's passion for oncology is evident in the nature of her career and she works to remind everyone that some patients can “get lost in the shuffle.” Sherin said, “These patients need the chronic care that they may not get if they're not ‘elderly'.”Many patients need support throughout their cancer journey and often, team members are stretched thin and act in a “reactive state” to address patient needs. Sherin is working to change this. She said, “So, I understand both the patient care aspects along with the balance that needs to be done with the bottom line of the center resources…”Communication and education play a vital role in addressing the knowledge gap and transforming care. Carevive's patient-reported outcomes act as a window into patient thoughts and ideas. Sherin explained, “[We]...let people know that this is something that's out there, that we can support you and your patients and understanding what's going on in between scheduled visits so that you can proactively engage with patients as opposed to that kind of reactive state…”

April Boyd, Sr. Clinical Content Developer at Carevive, is a nurse with many years of oncology experience. Boyd understands what it takes to achieve better patient outcomes. She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston. She spoke with Tyler Kern about her experiences and what led her to Carevive.Boyd joined Carevive in 2019 in content development to help create the company's remote symptom monitoring and management practice. She didn't intend to focus on oncology, but the fantastic people she encountered in the field and oncology practitioners' approach toward patient care and treatment resonated with her.Boyd's role at Carevive may differ from her nursing days, but it is no less rewarding. “It's super interesting to me,” Boyd said. “It always gets me excited to take the things we have that we're doing well and figure out how to do them even better.” Boyd acknowledged gaps in care where people are not getting the holistic care or equity of care they need.This motivates and informs her work at Carevive, which helps the company's “features resonate and be effective and valuable” for clinicians and patients alike. “It just gets me excited to be able to dig in and figure out which levers we can pull to get that right,” Boyd said.Boyd's previous experience working in oncology is paying off in her role with Carevive. “I understand how it is to be working with those patients, and talking to patients, and coming up against those care gaps,” Boyd said. “So, the conversation is very easy between me and the customers, or the patients who might be advising us, because I have that clinical experience.”

April Boyd, Sr. Clinical Content Developer at Carevive, is a nurse with many years of oncology experience. Boyd understands what it takes to achieve better patient outcomes. She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston. She spoke with Tyler Kern about her experiences and what led her to Carevive.Boyd joined Carevive in 2019 in content development to help create the company's remote symptom monitoring and management practice. She didn't intend to focus on oncology, but the fantastic people she encountered in the field and oncology practitioners' approach toward patient care and treatment resonated with her.Boyd's role at Carevive may differ from her nursing days, but it is no less rewarding. “It's super interesting to me,” Boyd said. “It always gets me excited to take the things we have that we're doing well and figure out how to do them even better.” Boyd acknowledged gaps in care where people are not getting the holistic care or equity of care they need. This motivates and informs her work at Carevive, which helps the company's “features resonate and be effective and valuable” for clinicians and patients alike. “It just gets me excited to be able to dig in and figure out which levers we can pull to get that right,” Boyd said.Boyd's previous experience working in oncology is paying off in her role with Carevive. “I understand how it is to be working with those patients, and talking to patients, and coming up against those care gaps,” Boyd said. “So, the conversation is very easy between me and the customers, or the patients who might be advising us, because I have that clinical experience.”

As a nurse turned content developer, Sharon Cavone has spent the majority of her career in and around oncology. Now with Carevive, Cavone reflects on the important work the company is continuing to put forth into the oncological sector of healthcare. Oncology is different from most other areas of medicine, as it provides insight into the patient, care, and life. “One of the things that is so incredible about oncology is that we connect with our patients. We develop relationships with our patients. Our patients look at us as their umbilical cord…we walk them over hot coals, is how I talk about…helping someone get through treatment and…we always want our patients to feel well,” Cavone said.Ultimately, Carevive's goal is to help patients continue to live life on the best terms they can. “…on the whole they're going to be better than what they could have been,” Cavone added. Beyond the relational aspect of oncology, Carevive helps set up and provide insight into each patient's individual experience. Using the Carevive platform with system management questions, clinicians can better prioritize and manage patient care. The assessment questions provided by Carevive are incredibly comprehensive, giving a great picture of patient reported outcomes and helping clinicians streamline the process of navigating the patient experience. Cavone said, “I feel like I understand what our clients are looking for…so I understand the kind of pitfalls that our clients have…we can use technology to do it better, we can use technology to mitigate things, to anticipate first and then mitigate and then solve. And that's what it's all about.”

As a nurse turned content developer, Sharon Cavone has spent the majority of her career in and around oncology. Now with Carevive, Cavone reflects on the important work the company is continuing to put forth into the oncological sector of healthcare. Oncology is different from most other areas of medicine, as it provides insight into the patient, care, and life. “One of the things that is so incredible about oncology is that we connect with our patients. We develop relationships with our patients. Our patients look at us as their umbilical cord…we walk them over hot coals, is how I talk about…helping someone get through treatment and…we always want our patients to feel well,” Cavone said.Ultimately, Carevive's goal is to help patients continue to live life on the best terms they can. “…on the whole they're going to be better than what they could have been,” Cavone added. Beyond the relational aspect of oncology, Carevive helps set up and provide insight into each patient's individual experience. Using the Carevive platform with system management questions, clinicians can better prioritize and manage patient care. The assessment questions provided by Carevive are incredibly comprehensive, giving a great picture of patient reported outcomes and helping clinicians streamline the process of navigating the patient experience. Cavone said, “I feel like I understand what our clients are looking for…so I understand the kind of pitfalls that our clients have…we can use technology to do it better, we can use technology to mitigate things, to anticipate first and then mitigate and then solve. And that's what it's all about.”

A career change can often come with uncertainty for the future, but for Christina Morgan, Clinical Practice Transformation Advisor at Carevive, it gave her a voice to advocate for cancer patients helping them receive the highest quality of care. Oncology and Technology host Tyler Kern sat with Morgan to discuss her transition from the field of nursing to clinical practice. Morgan's journey began after she graduated from nursing school. “I decided to go right into oncology, and I worked as an oncology nurse at a medical center for a few years. We handled everything from patients who were initially diagnosed, to handling symptom management and even end of life care,” she said. “It really was a spectrum working with the cancer oncology population.” Wanting to educate herself further, Morgan's path led her to the University of Central Florida (UCF) where she worked as a nurse practitioner in neuro-oncology helping lymphoma patients, and people with brain tumors and other neurologic disorders. “I realized I really wanted to provide care in a way that was a little bit more advanced than what I was doing. I want to be able to diagnose and treat people, to work with physicians, and to do things on a higher level, which going to UCF allowed me to do,” Morgan said. Now as a clinical practice transformation advisor at Carevive, her background allows her to have a clinical perspective. “Being in the medical community, not only over the decade but also being with the pandemic over the last two years, has shown me how much cancer patients need the right care and the right people advocating on their behalf,” she said. Cancer never hits anyone at the right time buthaving the resources and information to make decisions is key, Morgan explained. “I think there is a correlation that I can bring, not only to Carevive but to patients because I understand what they're going through and I think,at the end of the day,that's all we ever want to do is advocate for patients that are going through difficult and challenging situations,” she said. “But working with a companythat is making the life of a cancer patient so much easier, means a lot. It takes work and we do have to make the effort and at Carevive I know we're doing that.”

A career change can often come with uncertainty for the future, but for Christina Morgan, Clinical Practice Transformation Advisor at Carevive, it gave her a voice to advocate for cancer patients helping them receive the highest quality of care. Oncology and Technology host Tyler Kern sat with Morgan to discuss her transition from the field of nursing to clinical practice. Morgan's journey began after she graduated from nursing school. “I decided to go right into oncology, and I worked as an oncology nurse at a medical center for a few years. We handled everything from patients who were initially diagnosed, to handling symptom management and even end of life care,” she said. “It really was a spectrum working with the cancer oncology population.” Wanting to educate herself further, Morgan's path led her to the University of Central Florida (UCF) where she worked as a nurse practitioner in neuro-oncology helping lymphoma patients, and people with brain tumors and other neurologic disorders. “I realized I really wanted to provide care in a way that was a little bit more advanced than what I was doing. I want to be able to diagnose and treat people, to work with physicians, and to do things on a higher level, which going to UCF allowed me to do,” Morgan said. Now as a clinical practice transformation advisor at Carevive, her background allows her to have a clinical perspective. “Being in the medical community, not only over the decade but also being with the pandemic over the last two years, has shown me how much cancer patients need the right care and the right people advocating on their behalf,” she said. Cancer never hits anyone at the right time buthaving the resources and information to make decisions is key, Morgan explained. “I think there is a correlation that I can bring, not only to Carevive but to patients because I understand what they're going through and I think,at the end of the day,that's all we ever want to do is advocate for patients that are going through difficult and challenging situations,” she said. “But working with a companythat is making the life of a cancer patient so much easier, means a lot. It takes work and we do have to make the effort and at Carevive I know we're doing that.”

The ONS Congress brings together various skillsets and inspires innovation in new ways. With the first in-person Congress since the pandemic set to begin on April 27th, there is much to look forward to. John Elliott, VP of Sales with Carevive brings together his work colleagues to share their excitement for the Congress and what they think might come from it.Reesa Sherin, a Clinical Strategist with Carevive, said she is, “Really excited to be in a space…to support patients…I've always been in the oncology space…supporting patients throughout the treatment journey…and any education the patient may need.”Though the ONS Congress will take place on a hybrid platform, accessible via remote access or in-person, Sherin shared that she believes ONS will shed some light on new ways for the industry to build value-based programming with ONS as the tipping point, “When you align the value to the care that the patient receives the outcomes approve.”Her colleagues agree that ONS is a shared intellectual and innovative platform, “I want to learn from others, what they're doing regarding collection of prodata, patient reported outcomes. We know that studies show when pros are used to monitor and manage symptoms, patient symptoms are identified early, leading to longer time and relevant on-treatment, fewer hospitalizations, and better quality of life and overall, an improved survival,” said Drace Langford, Prompt Patient Support Specialist. April Boyd, Senior Content Developer, shared that she, “always comes away from ONS educated and inspired” and she hopes to continue learning how to continue to improve the health of patients “in a remote way.”Overall, the oncology ecosystem continues to change and innovate based on new models and systems in the space. Carevive aims to educate, inspire, and make positive change in the industry as a knowledge-base for all. Stop by the booth at the ONS Congress to learn more and chat with the Carevive team!

Cancer treatment and care can be complex and often focuses on quality of life. The ecosystem of care delivery touches many aspects, and most of these can see improvement with the power of data. Discussing the topic, Oncology and Technology host James Kent spoke with Aaron Galaznik, MD, Chief Scientific Officer of Carevive. Galaznik was on a path to becoming a physician when he learned about other healthcare avenues. “The year after college, I was interning as a hospital administrator with this career in mind. I was interested in measuring care and what measures are used,” he said.Those experiences led Galaznik to be very data-centric. He graduated from medical school and earned an MBA in healthcare management. Later, he spent time in life sciences with Pfizer before becoming more excited about using data and analytics and applying them to healthcare problems.

Cancer treatment and care can be complex and often focuses on quality of life. The ecosystem of care delivery touches many aspects, and most of these can see improvement with the power of data. Discussing the topic, Oncology and Technology host James Kent spoke with Aaron Galaznik, Chief Scientific Officer of Carevive. Galaznik was on a path to becoming a physician when he learned about other healthcare avenues. “The year after college, I was interning as a hospital administrator with this career in mind. I was interested in measuring care and what measures are used,” he said.

Carevive Vice President of Sales John Elliott joined host David Kemp to discuss how trade shows have provided the oncology and wider healthcare industry with value and started the year off on the right foot in 2022. “You've got providers, you've got med device, you have digital health solutions,” stated Elliott about the scope of ViVE 2022. One bold trend Elliott has noticed at trade shows is the patient-centered shift. “I think it puts more emphasis on the patient. I think that's been a big theme across Vive this week,” he told Kemp. Elliott noted that all aspects of health care, including consumerism, precision medicine, and where data is coming from, feed back to the patient.Elliott noted one example from the recent ACCC Business Summit. Representatives from The University of Texas Dell Medical School discussed their Cancer Care Reimagined model, which focuses on the whole persona and surrounding and supporting with appropriate care.

If there was ever a moment for healthcare organizations to assess their EMS systems' ability to handle data and workflow integration properly, that time is now. Oncology and Technology welcomed back Carvive's Director of Product Management, SarahLena Keckler, to lend her expertise and insights on the topic.“The more technology becomes a part of our lives, and of our healthcare, the more important it is that systems can talk to one another,” Keckler said. “No two systems are alike, and it's no secret that our healthcare has scattered technology. Today, no one system covers everything. And so, this term, EMR integration, is really critical because it gets right to the core of this issue and highlights the need for different systems to work together and share information.”The complexities of working inside a de-centralized healthcare system is a challenge when trying to track patient data, sometimes scattered over many doctors and hospitals. In addition, it poses barriers for both the patient and their care teams.“This potentially creates siloed information, and it leads to gaps in understanding of a person's complete medical situation,” Keckler said. Carvive recognizes the need to not create another place for patients and care teams to have to go for information. Hence, its solution integrates into a healthcare organization's current EMR platform.“We've reduced a little bit of burden and taken a small step forward in a more efficient, and therefore more effective healthcare system,” Keckler said. “The more systems can integrate with each other, the more complete the picture becomes for care team members, and more engaged for users.”And while having centralized access to data is essential, it's the proper integration into workflows that provides the measure of success. “The best data integration in the world is meaningless if nobody's using it,” Keckler said.

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass.Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients.The biggest takeaways from the show in Elliott's opinion are: • The investor community in attendance hoping to provide innovation resources• An eagerness for a collaborative approach• Acting on data-centric information• “The time is now” essenceOverall, attendees and exhibitors came equipped with a problem-solving mindset. Elliott believes the industry is on the precipice of something big with major tech vendors in attendance and companies thinking innovatively to solve problems. “You're pulling in skillsets or talent that traditionally hasn't been invested in or focused on healthcare; I think there has been a shift. A health system having an innovation team or even an own strategic investment team on where they can work with third party partners, and they're allocating their own investment or capital funds to fill gaps.”To put it short, it's disruptive to the industry in the best way and is one example of how the pandemic is having a positive impact on the healthcare industry. However, the pandemic has posed significant problems for many in healthcare, and oncology is no exception. Traditional chemo infusion was impacted by COVID-19, making it unsafe for the immune-compromised to receive treatment. Luckily, they were able to transition to an oral regimen for a safer patient experience. However, what was the downstream impact on those patients? Luckily, Carevive had the technology to help care teams better support their patients.Carevive serves as a cancer management platform for improving patient experience throughout the cancer journey. To find more information, visit Carevive.com or contact john.elliott@carevive.com.

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass.Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients.The biggest takeaways from the show in Elliott's opinion are: • The investor community in attendance hoping to provide innovation resources• An eagerness for a collaborative approach• Acting on data-centric information• “The time is now” essenceOverall, attendees and exhibitors came equipped with a problem-solving mindset. Elliott believes the industry is on the precipice of something big with major tech vendors in attendance and companies thinking innovatively to solve problems. “You're pulling in skillsets or talent that traditionally hasn't been invested in or focused on healthcare; I think there has been a shift. A health system having an innovation team or even an own strategic investment team on where they can work with third party partners, and they're allocating their own investment or capital funds to fill gaps.”To put it short, it's disruptive to the industry in the best way and is one example of how the pandemic is having a positive impact on the healthcare industry. However, the pandemic has posed significant problems for many in healthcare, and oncology is no exception. Traditional chemo infusion was impacted by COVID-19, making it unsafe for the immune-compromised to receive treatment. Luckily, they were able to transition to an oral regimen for a safer patient experience. However, what was the downstream impact on those patients? Luckily, Carevive had the technology to help care teams better support their patients.Carevive serves as a cancer management platform for improving patient experience throughout the cancer journey. To find more information, visit Carevive.com or contact john.elliott@carevive.com.

Patients and care teams benefit from electronic, patient-reported outcomes. John Elliott, vice president of sales at Carevive, and Rami Elsabeh, chief product officer at DTX, spoke with Oncology and Technology to stress the importance ePROs play across patient populations. DTX is a web-based ePRO tool that uses automated SMS surveys to connect with patients throughout their care episode. Elsabeh said this software allows for streamlined information exchange between patients and the care team. “ePROs historically have been predominantly used more in a research capacity,” Elliott said. “That was the original case for ePROs, and it was fairly removed from any type of reimbursement. What's really evolved is when you have major payers, and you have CMS, and you start looking at value-based reimbursement models, there is strong advocacy for ePROs.” Because ePROs were primarily a research tool, the original focus was data collection. “Nowadays, with the increase in value-based care, reimbursement being tied more and more to quality of care versus quantity of care, and the emphasis on patient outcomes and cost-reduction methods, the ePRO systems they need to have extended capabilities,” Elsabeh said. “What's huge about the evolution is the integration capabilities now,” Elliott said. “So, taking it from a fairly segmented, siloed, single research population to a standard of care for a much broader patient population with actionable capabilities for the care team. That's how you get to the improved outcomes.”

Patients utilizing Carevive's PROmpt engagement tool and ePRO systems now have an assistant they can rely on to help them. Meet CLARA, Carvive's Longitudinal Assessments, and Reporting Assistant. SarahLena Keckler, Director of Product Management at Carevive, and Nadia Still, Carevive's Senior Director of Client Success, walked Oncology and Technology's James Kent through how CLARA came about and how this virtual assistant will make a big difference in patient-reported outcomes. Studies show numerous benefits associated with patients actively reporting their symptoms, as well as letting their healthcare team know how they're doing from home, in making significant improvements in the patients outcomes. of active reporting by patients of their symptoms and letting their healthcare team know how they're doing from their home in making significant improvements in their outcomes. With these benefits in mind, Carvive created CLARA. CLARA is more than just an acronym for Carevive's Longitudinal Assessments and Reporting Assistant. In fact, Keckler describes CLARA as represents serving as someone to represent and assist patients as they navigate and use this Carevive PROmpt program throughout their cancer journey. “She was created to help humanize what could otherwise be an impersonal experience for patients.” Keckler said. “The goal is to keep patients connected,” Still added. “Every clinician's goal is to care for their patients and provide the best possible care that they can, and we think that CLARA really helps to extend those efforts.”

Patients utilizing Carevive's PROmpt engagement tool and ePRO systems now have an assistant they can rely on to help them. Meet CLARA, Carvive's Longitudinal Assessments, and Reporting Assistant. SarahLena Keckler, Director of Product Management at Carevive, and Nadia Still, Carevive's Senior Director of Client Success, walked Oncology and Technology's James Kent through how CLARA came about and how this virtual assistant will make a big difference in patient-reported outcomes. Studies show numerous benefits associated with patients actively reporting their symptoms, as well as letting their healthcare team know how they're doing from home, in making significant improvements in the patients outcomes. of active reporting by patients of their symptoms and letting their healthcare team know how they're doing from their home in making significant improvements in their outcomes. With these benefits in mind, Carvive created CLARA. CLARA is more than just an acronym for Carevive's Longitudinal Assessments and Reporting Assistant. In fact, Keckler describes CLARA as represents serving as someone to represent and assist patients as they navigate and use this Carevive PROmpt program throughout their cancer journey. “She was created to help humanize what could otherwise be an impersonal experience for patients.” Keckler said. “The goal is to keep patients connected,” Still added. “Every clinician's goal is to care for their patients and provide the best possible care that they can, and we think that CLARA really helps to extend those efforts.” “In the digital world, humanizing mascots, or animated mascots like this, are statistically proven to make people feel more comfortable with a product and provide a more meaningful experience,” Keckler said. Carevive believes CLARA can become a patient partner in their journey and will help them utilize the ePRO tool more regularly and effectively.

What trends today will kick off a new age for oncology practices? Madelyn Trupkin Herzfeld, CEO for Carevive, which is building technologies that improve the cancer patient treatment experience and survival outcomes while lowering costs, shared her thoughts and insights.With the pandemic adding layers of complexity to the already challenging world of cancer care, Herzfeld said it wasn't easy for healthcare providers to add new technology solutions during this time.“What you've heard most about is patients fearing coming in for screenings,” Herzfeld said. “So diagnostic testing and new cancer cases certainly haven't been identified, because patients have said they are going to put the screening off until after the pandemic.”One trend coming out of the pandemic is virtual consultations, which Herzfeld believes will continue long after COVID-19.“Virtual care is finding the right use cases in all areas of healthcare, but particularly in cancer care, where it's possible to do follow up consults virtually,” Herzfeld said. “You won't see that go away when the pandemic ends.”Carevive's solutions focus on patient-reported outcomes, and Herzfeld shared her excitement on the evolution of cancer care in this area and the many improvements to come.“Making sure that we understand what the patient is experiencing, what their symptoms are and how can we get in front of them to make the best quality of life when patients have advanced cancer,” Herzfeld said. “So that is taking front and center stage with all stakeholders in the cancer care industry.”One of the things Carevive is doing to help make cancer treatment better is remote patient monitoring.“Providers need a scalable technology to do remote patient monitoring, which is a positive thing we're able to provide them,” Herzfeld said. “We're also able to provide them with the insights from their data that can really help them improve their practice, improve the treatments they select for patients and improve their symptom management practices.”

Bruno Lempernesse possesses 25 years of experience in real-world patient data analytics and corporate leadership. Still, he wasn't job hunting when he received a call from Carevive's Co-founder Madelyn Trupkin Herzfeld.After that call, Lempernesse knew he wanted to be part of Carevive's mission to improve cancer patients' experiences through ePROs (electronic patient-reported outcomes). Joining Carvive as its new CEO in December of 2020, Lemperness sat down with host James Kent to discuss his new role and excitement about what Carevive is doing to disrupt the industry and provide better patient experiences and improved patient outcomes.Lempernesse, a marathon runner in his spare time, saw many similarities between that sport and what it takes to lead a company like Carevive.“For me, it's all about being well-prepared,” Lempernesse said. “You plan your actions like you're going to plan your run and your race. You understand your environment and your competition, too. You get the right technology and the right gear, and you want to be ready to adapt to changing conditions. And at the end of the day, you don't give up until you cross the finish line.”Some of the main focuses for Carevive under Lempernesse's leadership will be scaling Carevive's innovative cancer care digital platform to help cancer care teams monitor and manage their patients remotely between clinic visits.Carevive will also focus on increasing their remote patient management functionality (Carevive PROmpt®️), growing their Oncology Pragmatic Trial Investigator Network (Carevive OPT-IN®️), and building more vital evidence for treatment and symptom pathways.“Patients are really at the center of all we do and the center of our strategy and investment,” Lempernesse said. “What we're planning to do is accelerate our vision to collect and analyze real-world patient data. Combining clinical data, but also patient-reported outcomes, will help us to improve upon the cancer care experience continually.”

The oncology ecosystem is a sprawling one – but Carevive is proud to play a clear role in that landscape.John Elliott, Carevive Vice President, Sales, joined host Tyler Kern to introduce the organization and explain the work it does for a wide range of stakeholders in the world of oncology and cancer care.Carevive works to enhance patient outcomes, reduce costs and optimize revenue by building technologies that improve the cancer patient treatment experience and survival outcomes. Oncology providers, patients and life science researchers use Carevive with bi-directional EHR integration in routine clinical practice.Elliott and Kern explored a variety of key questions about the efforts Carevive makes to bring this vision to life, including current trends across cancer centers and cancer care, the most common pain points oncology stakeholders face, the benefits of strategic partnerships in furthering overall goals, and more.Carevive's platform is “centered on [its] proprietary Clinical Intelligence System, an algorithm-based engine that combines EHR data, evidence-based guidelines and patient-reported outcomes (PROs) into one solution.”This holistic approach is a powerful tool in the arsenal of organizations looking to better manage cancer care and boost patient outcomes and engagement while also paying attention to key drivers of growth, such as revenue.